Skip to main content

Table 3 The results of univariate and multivariate analysis of disease-free survival

From: Development of a nomogram based on the clinicopathological and CT features to predict the survival of primary pulmonary lymphoepithelial carcinoma patients

Characteristics

Univariate

Multivariate

HR (95% CI)

P-value

HR (95% CI)

P-value

Clinical factor

    

 Age (per 1-year increase)

1.00 (0.97–1.03)

0.993

1.03 (1.00-1.06)

0.057

 Gender (Male as ref.)

1.70 (0.87–3.33)

0.120

 Smoking status (Never as ref.)

1.88 (0.86–4.11)

0.112

 Symptom (Absence as ref.)

3.20 (1.69–6.07)

<0.001

 CYFRA21-1 (Normal as ref.)

4.14 (2.14–8.04)

<0.001

 Surgery resection (No as ref.)

0.15 (0.08–0.29)

<0.001

0.24 (0.11–0.55)

0.001

Pathologic factor

    

 T stage (T1/2 as ref.)

2.42 (1.27–4.62)

0.007

 M stage (M0 as ref.)

5.14 (2.37–11.13)

<0.001

Chest CT factor

    

 Morphology (Round/oval as ref.)

3.81 (1.33–10.94)

0.013

 Tumor site in lobe (Left as ref.)

0.64 (0.34–1.22)

0.176

 Hilar and/or mediastinal LAP (Absence as ref.)

5.55 (2.61–11.78)

<0.001

3.27 (1.39–7.70)

0.007

 Vascular encasement (Absence as ref.)

1.34 (0.71–2.55)

0.365

 Necrosis (Absence as ref.)

1.89 (0.90-4.00)

0.095

 Pleural and/or pericardial effusion (Absence as ref.)

3.90 (1.51–10.06)

0.005

 CT value (<37.8 HU as ref.)

3.14 (1.48–6.64)

0.003

1.98 (0.92–4.26)

0.079

  1. LAP, lymphadenopathy; CYFRA21-1, Cytokeratin fragment antigen 21 − 1; HR, Hazard ratio; CI Confidence interval; CT, Computed tomography